Skip to main content

Oribel Capital Management, LP

Position in DHR — Danaher Corp /De/

CIK 1661140 NEW YORK, NY

Position in DHR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$0
-$30,560,820 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
8 quarters on record

Common Shares in DHR Over Time

Shares Held

Position Value (USD)

Derivatives in DHR

reported options exposure · as of Jun 30, 2026
CallValue
$51,143,880
CallShares
268,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Oribel Capital Management, LP holds $26,967,879 across 2 Diagnostics & Research names.

# Ticker Company Shares Value (USD) Open

All Filings in DHR

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,143,880 268,500
2025-12-31 $30,560,820 133,500
2025-12-31 $30,560,820 133,500
2025-03-31 $34,153,000 166,600
2025-03-31 $34,153,000 166,600
2024-09-30 $46,735,162 168,100
2024-09-30 $46,735,162 168,100
2024-06-30 $27,808,305 111,300
2024-03-31 $12,486,000 50,000
2023-06-30 $4,200,000 17,500
2023-03-31 $28,530,925 113,200
2023-03-31 $28,530,925 113,200